Gene and Protein Expression Profiles of Anti‐ and Pro‐apoptotic Actions of Dopamine, R‐Apomorphine, Green Tea Polyphenol (−)‐Epigallocatechine‐3‐gallate, and Melatonin
Identifieur interne : 001765 ( Main/Exploration ); précédent : 001764; suivant : 001766Gene and Protein Expression Profiles of Anti‐ and Pro‐apoptotic Actions of Dopamine, R‐Apomorphine, Green Tea Polyphenol (−)‐Epigallocatechine‐3‐gallate, and Melatonin
Auteurs : Orly Weinreb [Israël] ; Silvia Mandel [Israël] ; Moussa B. H. Youdim [Israël]Source :
- Annals of the New York Academy of SciencesNEUROPROTECTIVE AGENTS: Sixth International Conference [ 0077-8923 ] ; 2003-05.
English descriptors
- KwdEn :
Abstract
Abstract: Significant evidence has been provided to support the hypothesis that oxidant stress may be responsible for degeneration of dopaminergic neurons in the substantia nigra pars compacta in Parkinson's disease. Dopamine (DA), R‐apomorphine (R‐APO), green tea polyphenol (−)‐epigallocatechine‐3‐gallate (EGCG), and melatonin are neuroprotective and radical scavenger compounds. The aim of this study was to establish the mechanism of the concentration‐dependent neuroprotective and pro‐apoptotic action of these drugs via gene expression and protein determination. cDNA microarrays provide new prospects to study and identify various mechanisms of drug action. We employed this technique for the study reported in this paper. Total RNA was extracted from SH‐SY5Y cells exposed to low neuroprotective and high toxic concentrations of the drugs, followed by synthesis of cDNA, and hybridization to a microarray membrane related to apoptosis, survival, and cell cycle pathways. We demonstrated a concentration and time‐dependent correlation between R‐APO, DA, EGCG, and melatonin in modulation of cell survival/cell death‐related gene pathways. The results were confirmed by quantitative real‐time PCR and protein profiles. Unlike the effects of low concentrations (1‐10 μM), where an antiapoptotic response was manifest, a proapoptotic pattern of gene expression was observed at high toxic concentrations (50‐500 μM) of the antioxidants (e.g., increase in caspases, fas, and gadd45). Our results have provided novel insights into the gene mechanisms involved in both the neuroprotective and proapoptotic activities of neuroprotective drugs. We have shown that DA, R‐APO, EGCG, and melatonin exhibit similar gene expression and protein profiles.
Url:
DOI: 10.1111/j.1749-6632.2003.tb07544.x
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Gene and Protein Expression Profiles of Anti‐ and Pro‐apoptotic Actions of Dopamine, R‐Apomorphine, Green Tea Polyphenol (−)‐Epigallocatechine‐3‐gallate, and Melatonin</title><author><name sortKey="Weinreb, Orly" sort="Weinreb, Orly" uniqKey="Weinreb O" first="Orly" last="Weinreb">Orly Weinreb</name></author><author><name sortKey="Mandel, Silvia" sort="Mandel, Silvia" uniqKey="Mandel S" first="Silvia" last="Mandel">Silvia Mandel</name></author><author><name sortKey="Youdim, Moussa B H" sort="Youdim, Moussa B H" uniqKey="Youdim M" first="Moussa B. H." last="Youdim">Moussa B. H. Youdim</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:F4F01C8FD2F1EDDAD59FD522A38722B8CDF3045B</idno><date when="2003" year="2003">2003</date><idno type="doi">10.1111/j.1749-6632.2003.tb07544.x</idno><idno type="url">https://api.istex.fr/document/F4F01C8FD2F1EDDAD59FD522A38722B8CDF3045B/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000E64</idno><idno type="wicri:Area/Main/Curation">000C96</idno><idno type="wicri:Area/Main/Exploration">001765</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Gene and Protein Expression Profiles of Anti‐ and Pro‐apoptotic Actions of Dopamine, R‐Apomorphine, Green Tea Polyphenol (−)‐Epigallocatechine‐3‐gallate, and Melatonin</title><author><name sortKey="Weinreb, Orly" sort="Weinreb, Orly" uniqKey="Weinreb O" first="Orly" last="Weinreb">Orly Weinreb</name><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Eve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research and Department of Pharmacology, Rappaport Family Research Institute, Technion‐Faculty of Medicine, Haifa</wicri:regionArea><wicri:noRegion>Haifa</wicri:noRegion></affiliation></author><author><name sortKey="Mandel, Silvia" sort="Mandel, Silvia" uniqKey="Mandel S" first="Silvia" last="Mandel">Silvia Mandel</name><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Eve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research and Department of Pharmacology, Rappaport Family Research Institute, Technion‐Faculty of Medicine, Haifa</wicri:regionArea><wicri:noRegion>Haifa</wicri:noRegion></affiliation></author><author><name sortKey="Youdim, Moussa B H" sort="Youdim, Moussa B H" uniqKey="Youdim M" first="Moussa B. H." last="Youdim">Moussa B. H. Youdim</name><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Eve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research and Department of Pharmacology, Rappaport Family Research Institute, Technion‐Faculty of Medicine, Haifa</wicri:regionArea><wicri:noRegion>Haifa</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Annals of the New York Academy of SciencesNEUROPROTECTIVE AGENTS: Sixth International Conference</title><idno type="ISSN">0077-8923</idno><idno type="eISSN">1749-6632</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2003-05">2003-05</date><biblScope unit="volume">993</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="351">351</biblScope><biblScope unit="page" to="361">361</biblScope></imprint><idno type="ISSN">0077-8923</idno></series><idno type="istex">F4F01C8FD2F1EDDAD59FD522A38722B8CDF3045B</idno><idno type="DOI">10.1111/j.1749-6632.2003.tb07544.x</idno><idno type="ArticleID">NYAS351</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0077-8923</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>antioxidants</term><term>cDNA array</term><term>cell death</term><term>cell survival</term><term>quantitative real‐time PCR</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Significant evidence has been provided to support the hypothesis that oxidant stress may be responsible for degeneration of dopaminergic neurons in the substantia nigra pars compacta in Parkinson's disease. Dopamine (DA), R‐apomorphine (R‐APO), green tea polyphenol (−)‐epigallocatechine‐3‐gallate (EGCG), and melatonin are neuroprotective and radical scavenger compounds. The aim of this study was to establish the mechanism of the concentration‐dependent neuroprotective and pro‐apoptotic action of these drugs via gene expression and protein determination. cDNA microarrays provide new prospects to study and identify various mechanisms of drug action. We employed this technique for the study reported in this paper. Total RNA was extracted from SH‐SY5Y cells exposed to low neuroprotective and high toxic concentrations of the drugs, followed by synthesis of cDNA, and hybridization to a microarray membrane related to apoptosis, survival, and cell cycle pathways. We demonstrated a concentration and time‐dependent correlation between R‐APO, DA, EGCG, and melatonin in modulation of cell survival/cell death‐related gene pathways. The results were confirmed by quantitative real‐time PCR and protein profiles. Unlike the effects of low concentrations (1‐10 μM), where an antiapoptotic response was manifest, a proapoptotic pattern of gene expression was observed at high toxic concentrations (50‐500 μM) of the antioxidants (e.g., increase in caspases, fas, and gadd45). Our results have provided novel insights into the gene mechanisms involved in both the neuroprotective and proapoptotic activities of neuroprotective drugs. We have shown that DA, R‐APO, EGCG, and melatonin exhibit similar gene expression and protein profiles.</div></front></TEI><affiliations><list><country><li>Israël</li></country></list><tree><country name="Israël"><noRegion><name sortKey="Weinreb, Orly" sort="Weinreb, Orly" uniqKey="Weinreb O" first="Orly" last="Weinreb">Orly Weinreb</name></noRegion><name sortKey="Mandel, Silvia" sort="Mandel, Silvia" uniqKey="Mandel S" first="Silvia" last="Mandel">Silvia Mandel</name><name sortKey="Youdim, Moussa B H" sort="Youdim, Moussa B H" uniqKey="Youdim M" first="Moussa B. H." last="Youdim">Moussa B. H. Youdim</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001765 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001765 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:F4F01C8FD2F1EDDAD59FD522A38722B8CDF3045B
|texte= Gene and Protein Expression Profiles of Anti‐ and Pro‐apoptotic Actions of Dopamine, R‐Apomorphine, Green Tea Polyphenol (−)‐Epigallocatechine‐3‐gallate, and Melatonin
}}
| This area was generated with Dilib version V0.6.23. |  |